The Risk Assessment Scale for Peripherally Inserted Central Venous Catheter (PICC) Related Thrombosis in Cancer Patients
1 other identifier
observational
281
1 country
1
Brief Summary
The aim of this study is to compare the accuracy and clinical predictive value of the Michigan Risk Score, Caprini Risk Assessment Model , and Maneval Scale (Chinese version)in predicting PICC-related thrombosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 18, 2023
CompletedFirst Posted
Study publicly available on registry
August 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2024
CompletedJuly 9, 2024
July 1, 2024
9 months
July 18, 2023
July 8, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
PICC thrombosis
symptomatic thrombosis,diagnosed by symptoms such as pain, tenderness and swelling of the affected part and the verification of color doppler ultrasound of venous vessels
through study completion,up to 1 year
The Michigan Risk Score
The risk score will be assessed. In this scale,risk factors associated with PICC-DVT included: history of DVT; multi-lumen PICC; active cancer; presence of another CVC when the PICC was placed; and white blood cell count greater than 12 000. The total score on the scale are 0 to 14 points, with a higher score indicates higher risk of thrombosis.
From date of PICC catheterization until the date of PICC removal or date of occurrence of PICC related thrombosis, whichever came first, assessed up to 12 months.
Maneval Scale
The risk score will be assessed. This scale includes 45 risk factors associated with PICC thrombosis. The total score on the scale are 0 to 45 points, with a higher score indicates higher risk of thrombosis.
From date of PICC catheterization until the date of PICC removal or date of occurrence of PICC related thrombosis, whichever came first, assessed up to 12 months.
Caprini Risk Assessment Model
The risk score will be assessed. This scale includes more than 40 risk factors associated with PICC thrombosis. In this scale,a higher score indicates higher risk of thrombosis.
From date of PICC catheterization until the date of PICC removal or date of occurrence of PICC related thrombosis, whichever came first, assessed up to 12 months.
Study Arms (1)
patients with PICC placement
Interventions
Patients with PICC placement will be assessed by the Michigan Risk Score, Caprini Risk Assessment Model , Maneval scale(Chinese version) to predict the risk of PICC-related thrombosis. The time of evaluation are the day during PICC placement, 24-48h after PICC placement, and every time when patients receive PICC maintenance.
Eligibility Criteria
cancer patients with PICC placement in Sun Yat-sen University Cancer Center
You may qualify if:
- Cancer patients
- Older than 18 years
- Being able to complete the questionnaire independently
- Patients who need PICC for treatment
- Being able to perform catheter maintenance in the hospital of admission until catheter removal
- Patients who agree to participate and sign the consent form
You may not qualify if:
- Patients who were or suspected to be allergic to the ingredients contained in PICC
- PICC placed in the lower extremity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Catheter Clinic
Guangzhou, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Infusion Therapy Specialist Nurse
Study Record Dates
First Submitted
July 18, 2023
First Posted
August 4, 2023
Study Start
April 1, 2023
Primary Completion
January 2, 2024
Study Completion
January 2, 2024
Last Updated
July 9, 2024
Record last verified: 2024-07